Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 47.84B | 46.43B | 41.37B | 36.90B | 34.82B | 31.98B |
Gross Profit | 12.84B | 12.40B | 8.93B | 8.53B | 9.47B | 8.09B |
EBITDA | 7.59B | 7.29B | 4.47B | 4.53B | 5.67B | 4.37B |
Net Income | 5.25B | 5.00B | 2.99B | 2.84B | 3.66B | 2.70B |
Balance Sheet | ||||||
Total Assets | 138.87B | 133.19B | 125.98B | 115.72B | 120.47B | 116.76B |
Cash, Cash Equivalents and Short-Term Investments | 92.84B | 89.13B | 83.59B | 75.43B | 82.41B | 80.23B |
Total Debt | 8.03B | 8.03B | 8.03B | 7.29B | 7.29B | 6.55B |
Total Liabilities | 109.36B | 105.33B | 101.06B | 94.16B | 91.58B | 87.56B |
Stockholders Equity | 29.52B | 27.86B | 24.92B | 21.56B | 28.89B | 29.20B |
Cash Flow | ||||||
Free Cash Flow | 9.63B | 9.07B | 7.71B | 6.46B | 7.27B | 6.52B |
Operating Cash Flow | 9.63B | 9.07B | 7.71B | 6.46B | 7.27B | 6.52B |
Investing Cash Flow | -7.61B | -7.26B | -6.82B | -3.73B | -5.20B | -4.89B |
Financing Cash Flow | -2.11B | -1.75B | -1.05B | -2.67B | -2.04B | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $62.25B | 12.23 | 19.29% | 1.54% | 8.54% | 43.51% | |
80 Outperform | $111.46B | 12.33 | 13.25% | 1.33% | 6.74% | -4.05% | |
77 Outperform | $28.83B | 17.30 | 18.94% | 1.75% | 11.41% | 15.32% | |
77 Outperform | $55.67B | 9.94 | 24.24% | 1.83% | 9.81% | 94.71% | |
73 Outperform | $24.05B | 11.46 | 16.24% | ― | 1.66% | 8.51% | |
64 Neutral | $1.23B | 25.33 | 3.82% | ― | -2.05% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |